Program of quality improvement for extracorporeal blood purification therapies in the intensive care unit
Journal of Clinical Monitoring and Computing · 2025
DOI: 10.1007/s10877-025-01396-7 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Monitoring and Computing, 2025. Verfasst von Matteo Cecchi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, Section of Anesthesiology, Intensive Care and Pain Medicine, University of Florence, Florence, Italy. Hauptthemen laut MEDLINE: Quality Improvement, Intensive Care Units, Critical Care, Hemofiltration. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Firenze.
Themen: Intensivpflege
Abstract (Originalsprache)
Critically ill patients often require complex extracorporeal treatments, such as extracorporeal blood purification (EBP). At the bedside, there can be reluctance or uncertainty about when to initiate EBP, and there is no standard agreement on which goals to pursue, what prescriptions to use to achieve those goals, or which recommendations to follow to prevent complications. Furthermore, an accurate analysis of why clinical goals are not achieved or how often the patient should be reassessed to readjust the EBP prescription is not currently standardized. This narrative review describes the main actions characterizing a quality improvement program for EBP in the ICU, which took place at the University of Florence and was subsequently adopted at the national level. The pillars of this program were: (1) definition, implementation, and dissemination of information and communication technology tools aimed at objectively measuring results at the bedside, supporting dynamic prescribing and precision medicine, and promoting advances in knowledge in this field; (2) creation of a national multi-professional network of clinical users and researchers in EBP; (3) promotion and maintenance of technical and non-technical skills in EBP based on the reformulation of advanced academic training in this field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Sciences, Section of Anesthesiology, Intensive Care and Pain Medicine, University of Florence, Florence, Italy.
- Department of Anesthesia and Intensive Care, ASST Santi Paolo e Carlo, San Paolo University Hospital, Milan, Italy.
- Unit of Accreditation, Quality and Risk Management, AOU Careggi, Florence, Italy.
- Department of Civil and Environmental Engineering, University of Florence, Florence, Italy.
- Department of Anesthesia and Critical Care, Meyer Children's University Hospital, IRCCS, Florence, Italy.
- Department of Anesthesia and Intensive Care, Section of Oncological Anesthesia and Intensive Care, AOU Careggi, Florence, Italy.
Förderung
- Università degli Studi di Firenze
Zitieren
APA
Cecchi, M., Pomarè Montin, D., Fioccola, A., Bocciero, V., Scirè Calabrisotto, C., Autieri, F., Benelli, M., Geppetti, A., Ricci, Z., Romagnoli, S., & Villa, G. (2025). Program of quality improvement for extracorporeal blood purification therapies in the intensive care unit. Journal of Clinical Monitoring and Computing. https://doi.org/10.1007/s10877-025-01396-7
Vancouver
Cecchi M, Pomarè Montin D, Fioccola A, Bocciero V, Scirè Calabrisotto C, Autieri F, et al. Program of quality improvement for extracorporeal blood purification therapies in the intensive care unit. Journal of Clinical Monitoring and Computing. 2025. doi:10.1007/s10877-025-01396-7
BibTeX
@article{Cecchi2025,
author = {Cecchi, Matteo and Pomarè Montin, Diego and Fioccola, Antonio and Bocciero, Vittorio and Scirè Calabrisotto, Caterina and Autieri, Filomena and Benelli, Manuela and Geppetti, Andrea and Ricci, Zaccaria and Romagnoli, Stefano and Villa, Gianluca},
title = {Program of quality improvement for extracorporeal blood purification therapies in the intensive care unit},
journal = {Journal of Clinical Monitoring and Computing},
year = {2025},
doi = {10.1007/s10877-025-01396-7}
}
EUVIMED